Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study

Flucloxacillin is an established cause of liver injury. Despite this, there are a lack of published data on both the strength of association after adjusting for potential confounders, and the absolute incidence among different subgroups of patients.To assess the relative and absolute risks of liver...

Full description

Bibliographic Details
Main Authors: Wing, K, Bhaskaran, K, Pealing, L, Root, A, Smeeth, L, van Staa, T, Klungel, O, Reynolds, R, Douglas, I
Format: Journal article
Language:English
Published: Oxford University Press 2017
_version_ 1797087701059502080
author Wing, K
Bhaskaran, K
Pealing, L
Root, A
Smeeth, L
van Staa, T
Klungel, O
Reynolds, R
Douglas, I
author_facet Wing, K
Bhaskaran, K
Pealing, L
Root, A
Smeeth, L
van Staa, T
Klungel, O
Reynolds, R
Douglas, I
author_sort Wing, K
collection OXFORD
description Flucloxacillin is an established cause of liver injury. Despite this, there are a lack of published data on both the strength of association after adjusting for potential confounders, and the absolute incidence among different subgroups of patients.To assess the relative and absolute risks of liver injury following exposure to flucloxacillin and identify subgroups at potentially increased risk.A cohort study between 1 January 2000 and 1 January 2012 using the UK Clinical Practice Research Datalink, including 1 046 699 people with a first prescription for flucloxacillin (861 962) or oxytetracycline (184 737). Absolute risks of experiencing both symptom-defined (jaundice) and laboratory-confirmed liver injury within 1-45 and 46-90 days of antibiotic initiation were estimated. Multivariable logistic regression was used to estimate 1-45 day relative effects.There were 183 symptom-defined cases (160 prescribed flucloxacillin) and 108 laboratory-confirmed cases (102 flucloxacillin). The 1-45 day adjusted risk ratio for laboratory-confirmed injury was 5.22 (95% CI 1.64-16.62) comparing flucloxacillin with oxytetracycline use. The 1-45 day risk of laboratory-confirmed liver injury was 8.47 per 100 000 people prescribed flucloxacillin (95% CI 6.64-10.65). People who received consecutive flucloxacillin prescriptions had a 1-45 day risk of jaundice of 39.00 per 100 000 (95% CI 26.85-54.77), while those aged >70 receiving consecutive prescriptions had a risk of 110.57 per 100 000 (95% CI 70.86-164.48).The short-term risk of laboratory-confirmed liver injury was >5-fold higher after a flucloxacillin prescription than an oxytetracycline prescription. The risk of flucloxacillin-induced liver injury is particularly high within those aged >70 and those who receive multiple flucloxacillin prescriptions. The stratified risk estimates from this study could help guide clinical care.
first_indexed 2024-03-07T02:39:26Z
format Journal article
id oxford-uuid:a9ec5ad2-0c43-4ca0-a322-c03a46ef9096
institution University of Oxford
language English
last_indexed 2024-03-07T02:39:26Z
publishDate 2017
publisher Oxford University Press
record_format dspace
spelling oxford-uuid:a9ec5ad2-0c43-4ca0-a322-c03a46ef90962022-03-27T03:11:42ZQuantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a9ec5ad2-0c43-4ca0-a322-c03a46ef9096EnglishSymplectic Elements at OxfordOxford University Press2017Wing, KBhaskaran, KPealing, LRoot, ASmeeth, Lvan Staa, TKlungel, OReynolds, RDouglas, IFlucloxacillin is an established cause of liver injury. Despite this, there are a lack of published data on both the strength of association after adjusting for potential confounders, and the absolute incidence among different subgroups of patients.To assess the relative and absolute risks of liver injury following exposure to flucloxacillin and identify subgroups at potentially increased risk.A cohort study between 1 January 2000 and 1 January 2012 using the UK Clinical Practice Research Datalink, including 1 046 699 people with a first prescription for flucloxacillin (861 962) or oxytetracycline (184 737). Absolute risks of experiencing both symptom-defined (jaundice) and laboratory-confirmed liver injury within 1-45 and 46-90 days of antibiotic initiation were estimated. Multivariable logistic regression was used to estimate 1-45 day relative effects.There were 183 symptom-defined cases (160 prescribed flucloxacillin) and 108 laboratory-confirmed cases (102 flucloxacillin). The 1-45 day adjusted risk ratio for laboratory-confirmed injury was 5.22 (95% CI 1.64-16.62) comparing flucloxacillin with oxytetracycline use. The 1-45 day risk of laboratory-confirmed liver injury was 8.47 per 100 000 people prescribed flucloxacillin (95% CI 6.64-10.65). People who received consecutive flucloxacillin prescriptions had a 1-45 day risk of jaundice of 39.00 per 100 000 (95% CI 26.85-54.77), while those aged >70 receiving consecutive prescriptions had a risk of 110.57 per 100 000 (95% CI 70.86-164.48).The short-term risk of laboratory-confirmed liver injury was >5-fold higher after a flucloxacillin prescription than an oxytetracycline prescription. The risk of flucloxacillin-induced liver injury is particularly high within those aged >70 and those who receive multiple flucloxacillin prescriptions. The stratified risk estimates from this study could help guide clinical care.
spellingShingle Wing, K
Bhaskaran, K
Pealing, L
Root, A
Smeeth, L
van Staa, T
Klungel, O
Reynolds, R
Douglas, I
Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study
title Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study
title_full Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study
title_fullStr Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study
title_full_unstemmed Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study
title_short Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study
title_sort quantification of the risk of liver injury associated with flucloxacillin a uk population based cohort study
work_keys_str_mv AT wingk quantificationoftheriskofliverinjuryassociatedwithflucloxacillinaukpopulationbasedcohortstudy
AT bhaskarank quantificationoftheriskofliverinjuryassociatedwithflucloxacillinaukpopulationbasedcohortstudy
AT pealingl quantificationoftheriskofliverinjuryassociatedwithflucloxacillinaukpopulationbasedcohortstudy
AT roota quantificationoftheriskofliverinjuryassociatedwithflucloxacillinaukpopulationbasedcohortstudy
AT smeethl quantificationoftheriskofliverinjuryassociatedwithflucloxacillinaukpopulationbasedcohortstudy
AT vanstaat quantificationoftheriskofliverinjuryassociatedwithflucloxacillinaukpopulationbasedcohortstudy
AT klungelo quantificationoftheriskofliverinjuryassociatedwithflucloxacillinaukpopulationbasedcohortstudy
AT reynoldsr quantificationoftheriskofliverinjuryassociatedwithflucloxacillinaukpopulationbasedcohortstudy
AT douglasi quantificationoftheriskofliverinjuryassociatedwithflucloxacillinaukpopulationbasedcohortstudy